Peter Rickenbacher

Novel concept to guide systolic heart failure medication by repeated biomarker testing—results from TIME-CHF in context of predictive, preventive, and personalized medicine

Joël M. H. Karel, Ralf Peeters, Nasser Davarzani, 2018, EPMA Journal.

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

Peter Buser, Thomas Suter, M. Pfisterer, 2009, JAMA.

Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

John Wikstrand, Johan Herlitz, Rainer Dietz, 2000 .

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

Patrick Hunziker, Christoph Kaiser, M. Pfisterer, 2006, Journal of the American College of Cardiology.

Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).

M. Pfisterer, P. Buser, H. Brunner-La Rocca, 2006, American heart journal.